ImmunoGen
IMGN
$31.23
Share price
0.00%
Change (1 day)
622.92%
Change (1 year)
Categories
ImmunoGen (IMGN) - P/B ratio
P/B ratio as of April 2024 : 15.5
According to ImmunoGen
's latest financial reports the company has a price-to-book ratio of 15.5.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
ImmunoGen - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 14.1 | 101.11% |
| 2022-12-31 | 7.03 | 40.08% |
| 2021-12-31 | 5.02 | -64.22% |
| 2020-12-31 | 14.0 | -239.25% |
| 2019-12-31 | -10.1 | -115.41% |
| 2018-12-31 | 65.4 | -237.97% |
| 2017-12-31 | -47.4 | 3159.45% |
| 2016-12-31 | -1.45 | -97.95% |
| 2015-12-31 | -70.8 | -1144.34% |
| 2014-12-31 | 6.78 | -29.84% |
| 2013-12-31 | 9.66 | 22.39% |
| 2012-12-31 | 7.89 | 2.86% |
| 2011-12-31 | 7.67 | -4.76% |
| 2010-12-31 | 8.06 | -17.15% |
| 2009-12-31 | 9.73 | 83.77% |
| 2008-12-31 | 5.29 | 57.95% |
| 2007-12-31 | 3.35 | 3.02% |
| 2006-12-31 | 3.25 | 23.67% |
| 2005-12-31 | 2.63 | -32.6% |
| 2004-12-31 | 3.90 | 85.14% |
| 2003-12-31 | 2.11 | 91.61% |
| 2002-12-31 | 1.10 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.12 | -67.04% | 🇺🇸 USA |
 Novartis NVS | 4.25 | -72.62% | 🇨🇭 Switzerland |
 Pfizer PFE | 1.61 | -89.63% | 🇺🇸 USA |
 Eli Lilly LLY | 64.1 | 312.70% | 🇺🇸 USA |
 Amgen AMGN | 23.2 | 49.58% | 🇺🇸 USA |
 Sanofi SNY | 1.49 | -90.38% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | 3.09 | -80.14% | 🇺🇸 USA |
 Seagen
SGEN | 16.9 | 8.92% | 🇺🇸 USA |